PanAgora Pharma conferences facilitate conversations from different perspectives aimed at alignment and establishing best practices to unify all stakeholders towards a patient-centric future of healthcare.
PanAgora Pharma is pleased to present the 6th Annual Clinical Trials Patient Experience Summit, hosted in partnership with Bristol Myers Squibb on September 21, 2020.
Now in it's second year with Bristol Myers Squibb as the Host Sponsor, the conference is the leading meeting place for those looking to improve the patient experience in clinical studies by including patients in the development process – while developing solutions to make the clinical trial process more convenient for patients, and more efficient for researchers.
20+ speakers are slated to take part from Bristol Myers Squibb, Pfizer, Novartis, Janssen R&D, FORCE, SCRS, Man Up To Cancer, Crohn's and Colitis Foundation, BlackHealthMatters, Syneos, Medable and many more will be sharing their experience this time around!
More than 250 representatives from Life Sciences, Pharmaceuticals, CROs, Recruitment and Research Sites, Patient Groups and Advocates, Clinical Trials Innovators, and technology providers that are improving the patient experience in clinical studies are registered to attend.
Now in it's second year with Bristol Myers Squibb as the Host Sponsor, the conference is the leading meeting place for those looking to improve the patient experience in clinical studies by including patients in the development process – while developing solutions to make the clinical trial process more convenient for patients, and more efficient for researchers.
20+ speakers are slated to take part from Bristol Myers Squibb, Pfizer, Novartis, Janssen R&D, FORCE, SCRS, Man Up To Cancer, Crohn's and Colitis Foundation, BlackHealthMatters, Syneos, Medable and many more will be sharing their experience this time around!
More than 250 representatives from Life Sciences, Pharmaceuticals, CROs, Recruitment and Research Sites, Patient Groups and Advocates, Clinical Trials Innovators, and technology providers that are improving the patient experience in clinical studies are registered to attend.
Location
Bristol Myers Squibb
Virtual Meeting
Virtual Meeting
Date & Time
September 21, 2020 - 9:00a - 4:15p EDT
HOSTED WITH
Bridging the Patient-Centricity Gaps between
Industry, Sites, Patients & Technology Enterprises
Industry, Sites, Patients & Technology Enterprises
Core Themes:
1. Patient Centricity By Design:
Clinical Trial Solutions Designed by Patients for Patients
2. Partnering with Patient Advocacy Groups:
Creating Meaningful Patient Engagement Across the Drug Development Continuum
3. Clinical Trial Sites and Recruitment During Our New COVID-19 Environment
Lessons Learned in Site Selection and Site Engagement
4. The Pharma Perspective:
Moving the Value Chain to a More Patient-Centric Pharma
5. Study Design and Diversity:
The Need for Increased Representation Across Clinical Trials to Ensure Inclusivity for the Patient and Caregiver
6. Innovation and Technology in Clinical Trial Design:
Designing Patient Tools and Solutions to Increase Participation in Clinical Trials
1. Patient Centricity By Design:
Clinical Trial Solutions Designed by Patients for Patients
2. Partnering with Patient Advocacy Groups:
Creating Meaningful Patient Engagement Across the Drug Development Continuum
3. Clinical Trial Sites and Recruitment During Our New COVID-19 Environment
Lessons Learned in Site Selection and Site Engagement
4. The Pharma Perspective:
Moving the Value Chain to a More Patient-Centric Pharma
5. Study Design and Diversity:
The Need for Increased Representation Across Clinical Trials to Ensure Inclusivity for the Patient and Caregiver
6. Innovation and Technology in Clinical Trial Design:
Designing Patient Tools and Solutions to Increase Participation in Clinical Trials
Schedule
Updated Weekly!
9:00 - 9:25 AM
Welcome and Opening Remarks
Kate Owen
Senior Vice President, Global Development Operations
Bristol Myers Squibb
Senior Vice President, Global Development Operations
Bristol Myers Squibb
9:25 - 10:30 AM
Patient-Centricity in Clinical Trial Design
9:25 - 9:55 AM
PATIENT KEYNOTE
Words Matter: The importance of Frequent Communication between Participants and Providers throughout Clinical Trials
Words Matter: The importance of Frequent Communication between Participants and Providers throughout Clinical Trials
MarlaJan Wexler, BSN, RN, CPN
Pediatric Registered Nurse
CEO/Founder, Luck Fupus, LLC
Patient Advocate, Survivor
9:55 - 10:25 AM
Providing Meaningful Closure to the Clinical Trials Participant Journey
David Leventhal
Sr. Director, Clinical Trial Experience
Pfizer
10:25 - 10:45 AM
BREAK
10:45 - 11:45 AM
Partnering with Patient Advocacy Groups
Creating Meaningful Patient Engagement Across the Drug Development Continuum
Creating Meaningful Patient Engagement Across the Drug Development Continuum
Led by:
Helen Kellar-Wood, Patient & Site Engagement Lead, Global Development Operations. Bristol Myers Squibb
Dyan Bryson
Founder
Inspired Health Strategies
Sue Friedman
Executive Director
Facing Our Risk of Cancer Empowered (FORCE)
Catherine Soto
Director of Patient Advocacy
Crohn's and Colitis Foundation
Brian McMahon
Founder
SparkCures
11:45 - 12:25 PM
Clinical Trial Sites and Recruitment During Our New COVID-19 Environment
Lessons Learned in Site Selection and Site Engagement
Lessons Learned in Site Selection and Site Engagement
Karen McIntyre, MSc Clinical Trials
Senior Director, Global Lead Catalyst Program & Site Relationships
Syneos Health
Ana Marquez, MSF
CEO, Clinical Site Partners
SCRS Summit Committee Member
Senior Director, Global Lead Catalyst Program & Site Relationships
Syneos Health
Ana Marquez, MSF
CEO, Clinical Site Partners
SCRS Summit Committee Member
12:30 - 1:15 PM
BREAK FOR LUNCH AND NETWORKING IN THE PLATFORM!
1:15 - 1:40 PM
PATIENT KEYNOTE
“Why Men are Missing Out on Clinical Trials”
“Why Men are Missing Out on Clinical Trials”
I’ve been living with stage IV colon cancer since March of 2018. Since diagnosis, I have gone through colon surgery, two liver surgeries, and traditional chemotherapy. I started immunotherapy in September 2019, and am currently stable, giving me cherished time with family and friends.
I recently founded a purpose-driven company called Man Up to Cancer. My mission is to inspire men to connect and avoid isolation during our cancer journeys. Numerous studies have shown that men tend to isolate after a cancer diagnosis. Men often don’t seek second opinions, and don’t lean about their treatment options. Consequently, men are missing out on trial opportunities that might provide them with the best chance of survival.
How do we bridge this gap? We need to encourage men to take control of their health by becoming students of their disease. Much of this learning happens within trusted advocacy organizations. Stakeholders in the clinical research space should be allies in this education. You can continue to build authentic relationships with patient advocacy organizations, and help them build resources and tools that connect their members with trial opportunities.
Trevor Maxwell
Founder and Pack Wolf
Man Up to Cancer
1:40 - 2:00 PM
The Pharma Perspective
Moving the Value Chain to a More Patient-Centric Pharma
Moving the Value Chain to a More Patient-Centric Pharma
Keynote by:
Samit Hirawat, M.D.
Executive Vice President, Chief Medical Officer, Global Drug Development
Bristol Myers Squibb
2:00 - 2:50 PM
Study Design and Diversity:
The Need for Increased Representation Across Clinical Trials to Ensure Inclusivity for the Patient and Caregiver
The Need for Increased Representation Across Clinical Trials to Ensure Inclusivity for the Patient and Caregiver
Moderated by:
Roslyn Daniels
President and Founder
Black Health Matters
Ruben Mesa, M.D
Director, Mays Center, UT Health San Antonio MD Anderson
Dan Milam
Vice President, Global Engagement
Society for Clinical Research Sites
Cassandra Smith, MBA
Director, Diversity & Inclusion in Clinical Trials
The Janssen Pharmaceutical Companies of Johnson & Johnson
2:50 - 3:00 PM
BREAK!
Sponsored by Medable
3:00 - 3:20 PM
Innovation and Technology in Clinical Trial Design
Delivering Patient-Centric Decentralised Solutions - Considerations, Experience and Evidenced Methods
Delivering Patient-Centric Decentralised Solutions - Considerations, Experience and Evidenced Methods
Alison Holland
Head of Virtual Clinical Trials
Medable
3:20 - 4:15 PM
Innovation and Technology in Clinical Trial Design
Designing Patient Tools and Solutions to Increase Participation in Clinical Trials
Designing Patient Tools and Solutions to Increase Participation in Clinical Trials
Moderated by:
Hassan Kadhim
Director, Global Head of Clinical Trial Business Capabilities and Clinical Innovation
Bristol Myers Squibb
Craig Lipset
Founder
Clinical Innovation Partners
Craig Serra
Global Head, Innovation, Data Operations
Novartis
Kelly McKee
Sr. Director, Patient Recruitment and Registries
Medidata
4:15 - 4:30 PM
Closing Remarks
Led by:
Lorena Kuri
Head, Diversity Strategy
Bristol Myers Squibb
Clinical Trials Patient Experience Summit 2020
2020 Speakers and Advisors
Samit Hirawat
EVP, Chief Medical Officer, Global Drug Development
EVP, Chief Medical Officer, Global Drug Development
BMS
Sharon Hanlon
Head of Clinical Trial Engagement & Enrollment
Head of Clinical Trial Engagement & Enrollment
BMS
Hassan Kadhim
Director, Head of Clinical Trial Business Capabilities
Director, Head of Clinical Trial Business Capabilities
BMS
Kate Owen
SVP, Global Development Operations
SVP, Global Development Operations
BMS
Craig Lipset
Founder
Founder
CLINICAL INNOVATION PARTNERS
Sue Friedman
Executive Director
Executive Director
FACING OUR RISK EMPOWERED
David Leventhal
Sr. Director, Clinical Trial Experience
Sr. Director, Clinical Trial Experience
PFIZER
Roslyn Daniels
Founder
Founder
BLACK HEALTH MATTERS
Craig Serra
Global Head, Innovation, Data Operations
Global Head, Innovation, Data Operations
NOVARTIS
Candace Howell
Engagement Strategy Lead
Engagement Strategy Lead
BMS
Ruben Mesa
Director, Mays Center
Director, Mays Center
UT Health San Antonio MD Anderson
Helen Kellar-Wood
Lead, Diversity & Patient Engagement
Lead, Diversity & Patient Engagement
BMS
Dan Milam
VP, Global Engagement
VP, Global Engagement
SCRS
Cassandra Smith
Director, Diversity & Inclusion in Clinical Trials
Director, Diversity & Inclusion in Clinical Trials
JANSSEN
TJ Sharpe
PATIENT ADVOCATE
Karen McIntyre, MSc Clinical Trials
Sr Director, Global Lead Catalyst Program & Site Relationships
Sr Director, Global Lead Catalyst Program & Site Relationships
SYNEOS
Dyan Bryson
Patient Advocate
Patient Advocate
INSPIRED HEALTH STRATEGIES
Brian McMahon
Founder
Founder
SPARKCURES
Ali Holland
Head of Virtual Clinical Trials
Head of Virtual Clinical Trials
MEDABLE
Lorena Kuri
Head, Diversity Strategy
Head, Diversity Strategy
BMS
Kelly McKee
Sr. Director, Patient Recruitment & Registries
Sr. Director, Patient Recruitment & Registries
MEDIDATA
Trevor Maxwell
Author & Founder
Author & Founder
MAN UP TO CANCER
MarlaJan Wexler, RN
CEO, Founder
CEO, Founder
LUCK FUPUS
Catherine Soto
Director of Patient Advocacy
Director of Patient Advocacy
CROHN's AND COLITIS FOUNDATION
Questions about the conference?
Interested in Sponsorship & Exhibition Opportunities?
Interested in Sponsorship & Exhibition Opportunities?
Location
Bristol-Myers Squibb - Virtual Event
Information on the 2019 venue:
Bristol-Myers Squibb’s new 650,000-square-foot, four-building campus, the culture is one of connectivity, spontaneity and collaboration. As a co-location for 2,100 employees previously spread across five sites, the project gives rise to a connected culture via a four-story atrium that bridges the various buildings. A variety of informal lounge, meeting and work settings provide much needed touch-down space for the highly mobile workforce. Outfitted with work settings and cafes, the atrium serves as the heart of the campus — and a key example of design for the human experience.
Bristol-Myers Squibb’s new 650,000-square-foot, four-building campus, the culture is one of connectivity, spontaneity and collaboration. As a co-location for 2,100 employees previously spread across five sites, the project gives rise to a connected culture via a four-story atrium that bridges the various buildings. A variety of informal lounge, meeting and work settings provide much needed touch-down space for the highly mobile workforce. Outfitted with work settings and cafes, the atrium serves as the heart of the campus — and a key example of design for the human experience.
Join us at Clinical Trials Patient Experience Summit 2020
BRIDGING THE PATIENT-CENTRICITY GAPS BETWEEN INDUSTRY, SITES, PATIENTS & TECHNOLOGY ENTERPRISES